---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-024938"
form_type: "8-K"
ticker: "SSII"
cik: "0001676163"
company_name: "SS Innovations International, Inc."
filed_at: "2026-03-09T23:59:59+00:00"
generated_at: "2026-05-15T17:55:24.271893+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# SS Innovations completes $18.6M private placement; funds expansion, FDA review mid-2026

## Summary
- Raised $18.6M gross via private placement of 5,774,839 shares at $3.00-$4.01 per share.
- Insiders invested $5.2M: CEO ($2.0M), Vice Chairman Moll ($2.0M), Director Adams ($1.2M).
- External investors, led by Manipal Global Health Services, invested $13.4M at $3.00/share.
- Proceeds for working capital, global expansion, and preparation for US/EU market entry.
- FDA 510(k) review for SSi Mantra system expected mid-2026; CE marking targeted in 2026.

## SEC filing metadata
- accession: 0001213900-26-024938
- form_type: 8-K
- ticker: SSII
- cik: 0001676163
- company_name: SS Innovations International, Inc.
- filed_at: 2026-03-09T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1676163/000121390026024938/0001213900-26-024938-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1676163/000121390026024938/ea0280514-8k_ssinno.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-024938
- JSON: https://secwatch.observer/filing/0001213900-26-024938.json
- Plain text: https://secwatch.observer/filing/0001213900-26-024938.txt

## Key facts
- Equity Issuances
  SS Innovations International, Inc. issued warrants to purchase 41,667 shares of our common stock of warrant to a FINRA member firm for exercise price of $3.45 per share.
  - Security: warrant
  - Shares: warrants to purchase 41,667 shares of our common stock
  - Purchaser: a FINRA member firm
  - Consideration: exercise price of $3.45 per share
  source text: the Company will pay a FINRA member firm a cash commission of $175,000 (7% of the investment) and issue to such firm five-year warrants to purchase 41,667 shares of our common stock at an exercise price of $3.45 per share
  evidence_url: https://www.sec.gov/Archives/edgar/data/1676163/000121390026024938/0001213900-26-024938-index.htm
- Equity Issuances
  SS Innovations International, Inc. issued 1,300,006 shares of common stock to Dr. Sudhir Srivastava, Dr. Frederic Moll, and Tim Adams for at an average price of $4.00 per share for a total of approximately $5.2 million.
  - Security: common stock
  - Shares: 1,300,006 shares
  - Purchaser: Dr. Sudhir Srivastava, Dr. Frederic Moll, and Tim Adams
  - Consideration: at an average price of $4.00 per share for a total of approximately $5.2 million
  source text: an aggregate of 1,300,006 shares of common stock at an average price of $4.00 per share for a total of approximately $5.2 million, to Dr. Sudhir Srivastava, our Chairman and Chief Executive Officer (498,753 shares at $4.01 per share for a total of $2.0 million), Dr. Frederic Moll, our Vice Chairman (501,253 shares at $3.99 per share for a total of $2.0 million), and Tim Adams, a director (300,000 shares at $3.99 per share for a total of $1.2 million)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1676163/000121390026024938/0001213900-26-024938-index.htm
- Equity Issuances
  SS Innovations International, Inc. issued 4,474,833 shares of common stock of common stock to existing and new investors, led by Manipal Global Health Services for at $3.00 per share for a total of approximately $13.4 million.
  - Security: common stock
  - Shares: 4,474,833 shares of common stock
  - Purchaser: existing and new investors, led by Manipal Global Health Services
  - Consideration: at $3.00 per share for a total of approximately $13.4 million
  source text: an aggregate of 4,474,833 shares of common stock at $3.00 per share for a total of approximately $13.4 million, to existing and new investors, led by Manipal Global Health Services
  evidence_url: https://www.sec.gov/Archives/edgar/data/1676163/000121390026024938/0001213900-26-024938-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.